Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan S Rice

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The Lancet. Respiratory Medicine|June 28, 2021
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysisWilliam W Busse, Sally E Wenzel, Thomas B Casale, et al.
ERJ Open Research|February 4, 2020
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthmaMario Castro, Klaus F Rabe, Jonathan Corren, et al.
Journal of Asthma and Allergy|December 28, 2020
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung FunctionIan D Pavord, Salman Siddiqui, Alberto Papi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 10, 2021
Prolactin and Risk of Epithelial Ovarian CancerCassandra A Hathaway, Megan S Rice, Mary K Townsend, et al.
Breast Cancer Research and Treatment|March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristicsMegan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 16, 2019
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic AsthmaJonathan Corren, Mario Castro, Thomas O'Riordan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2020
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitisWilliam W Busse, Jorge F Maspero, Yufang Lu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 28, 2019
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic RhinosinusitisJorge F Maspero, Constance H Katelaris, William W Busse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2020
Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort ConsortiumRenée T Fortner, Megan S Rice, Synnove F Knutsen, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Lancet. Respiratory Medicine|June 28, 2021
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysisWilliam W Busse, Sally E Wenzel, Thomas B Casale, et al.
ERJ Open Research|February 4, 2020
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthmaMario Castro, Klaus F Rabe, Jonathan Corren, et al.
Journal of Asthma and Allergy|December 28, 2020
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung FunctionIan D Pavord, Salman Siddiqui, Alberto Papi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 10, 2021
Prolactin and Risk of Epithelial Ovarian CancerCassandra A Hathaway, Megan S Rice, Mary K Townsend, et al.
Breast Cancer Research and Treatment|March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristicsMegan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 16, 2019
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic AsthmaJonathan Corren, Mario Castro, Thomas O'Riordan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2020
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitisWilliam W Busse, Jorge F Maspero, Yufang Lu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 28, 2019
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic RhinosinusitisJorge F Maspero, Constance H Katelaris, William W Busse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2020
Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort ConsortiumRenée T Fortner, Megan S Rice, Synnove F Knutsen, et al.
Pageof 6